Physician profile
Robert A Cook
NPI 1689057085
$2,302.86
in general payments reported to CMS, 2019-2025
22 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $57.59 · 2021: $306 · 2022: $538 · 2023: $240 · 2024: $556 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,219.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $339.59 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Biotissue Holdings INC. | $321.15 | 2023-2024 | |
| Kala Pharmaceuticals, INC. | $284.42 | 2021-2022 | |
| Notal Vision, INC. | $268.03 | 2022 | |
| Oyster Point Pharma, INC. | $267.28 | 2022-2024 | Tyrvaya |
| Dompe US, INC. | $140.00 | 2019-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $112.86 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $99.10 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $89.06 | 2025 | Tryptyr, Eysuvis, Rocklatan |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $81.93 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $45.86 | 2019 | |
| Harrow Eye, LLC | $42.75 | 2024-2025 | Vevye |
| Lumenis, INC | $32.76 | 2021 | |
| Celularity INC. | $31.70 | 2020 | |
| Abbvie INC. | $29.11 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $23.33 | 2019 | |
| Mallinckrodt Hospital Products INC. | $22.02 | 2020 | |
| Thea Pharma INC. | $20.36 | 2025 | Iyuzeh |
| Allergan, INC. | $16.22 | 2021 | |
| Visioneering Technologies, INC. | $16.07 | 2019 | |
| Eyevance Pharmaceuticals LLC | $15.39 | 2019 | |
| Rxsight INC | $3.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.